Effects of Fish Oil with a High Content of n-3 Polyunsaturated Fatty Acids on Mouse Gut Microbiota

Archives of Medical Research

Volumn 45, Issue 3, 2014, Pages 195-202

  Yu, Hai Ning ^a   Zhu, Jing ^a   Pan, Wen sheng ^b   Shen, Sheng Rong ^c   Shan, Wei Guang ^a   Das, Undurti N ^d  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d UND Life Sciences   (United States)

Author keywords

Fish oil; Gut microbiota; PCR DGGE; Phylogenetic analysis

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; GENOMIC DNA; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RIBOSOME RNA; RNA 16S;

ANIMAL EXPERIMENT; ARTICLE; CLONE; CLOSTRIDIALES; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; DRUG EFFECT; FEMALE; FIRMICUTES; HELICOBACTER; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PSEUDOMONAS; RANDOMIZATION; SPHINGOMONADALES; SUPPLEMENTATION;

FISH OIL; GUT MICROBIOTA; PCR-DGGE; PHYLOGENETIC ANALYSIS;

ANIMALS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; INTESTINES; MALE; MICE; MICE, INBRED ICR; MICROBIOTA; PHYLOGENY;

EID: 84899527723     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.03.008     Document Type: Article

References (56)

1. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
2. Festi D., Schiumerini R., Birtolo C., et al. Gut microbiota and its pathophysiology in disease paradigms. Dig Dis 2011, 29:518-524.
3. Ghorbanihaghjo A., Safa J., Alizadeh S., et al. Protective effect of fish oil supplementation on DNA damage induced by cigarette smoking. J Health Popul Nutr 2013, 31:343-349.
4. Jia D., Heng L.J., Yang R.H., et al. Fish oil improves learning impairments of diabetic rats by blocking PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways. Neuroscience 2014, 258:228-237.
5. Borghetti G., Yamazaki R.K., Coelho I., et al. Tumor growth reduction is regulated at the gene level in Walker 256 tumor-bearing rats supplemented with fish oil rich in EPA and DHA. Braz J Med Biol Res 2013, 46:696-699.
6. Liu T., Hougen H., Vollmer A.C., et al. Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids. Anaerobe 2012, 18:331-337.
7. Ghosh S., DeCoffe D., Brown K., et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 2013, 8:e55468.
8. Broekaert K., Heyndrickx M., Herman L., et al. Seafood quality analysis: Molecular identification of dominant microbiota after ice storage on several general growth media. Food Microbiol 2011, 28:1162-1169.
9. Huber T., Faulkner G., Hugenholtz P. Bellerophon: a program to detect chimeric sequences in multiple sequence alignments. Bioinformatics 2004, 20:2317-2319.
10. Mansfield G.S., Desai A.R., Nilson S.A., et al. Characterization of rainbow trout (Oncorhynchus mykiss) intestinal microbiota and inflammatory marker gene expression in a recirculating aquaculture system. Aquaculture 2010, 307:95-104.
11. Navarrete P., Magne F., Mardones P., et al. Molecular analysis of intestinal microbiota of rainbow trout (Oncorhynchus mykiss). FEMS Microbiol Ecol 2010, 71:148-156.
12. Osei-Poku J., Mbogo C.M., Palmer W.J., et al. Deep sequencing reveals extensive variation in the gut microbiota of wild mosquitoes from Kenya. Mol Ecol 2012, 21:5138-5150.
13. Mahenthiralingam E., Baldwin A., Drevinek P., et al. Multilocus sequence typing breathes life into a microbial metagenome. PLoS One 2006, 20:e17.
14. Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 1993, 59:695-700.
15. Handschur M., Pinar G., Gallist B., et al. Culture free DGGE and cloning based monitoring of changes in bacterial communities of salad due to processing. Food Chem Toxicol 2005, 43:1595-1605.
16. Kalliomäki M., Kirjavainen P., Eerola E., et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was not developing. Allergy Clin Immunol 2001, 107:129-134.
17. Salminen S., Gibson G.R., McCartney A.L., et al. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004, 53:1388-1389.
18. Eggesbo M., Botten G., Stigum H., et al. Is delivery by cesarean section a risk factor for food allergy. Allergy Clin Immunol 2003, 112:420-426.
19. Hällström M., Eerola E., Vuento R., et al. Effects of mode of delivery and necrotising enterocolitis on the intestinal microflora in preterm infants. Eur J Clin Microbiol Infect Dis 2004, 23:463-470.
20. Penders J., Thijs C., Vink C., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
21. Fanaro S., Chierici R., Guerrini P., et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr 2003, 91:48-55.
22. Altschul S.F., Gish W., Miller W., et al. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
23. Venter J.C., Remington K., Heidelberg J.F., et al. Environmental genome shotgun sequencing of the Sargasso sea. Science 2004, 304:66-74.
24. Turnbaugh P.J., Backhed F., Fulton L., et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. J Cell Host Microbe 2008, 3:213-223.
25. Levine U.Y., Looft T., Allen H.K., et al. Butyrate-producing bacteria, including mucin degraders, from the swine intestinal tract. Appl Environ Microbiol 2013, 79:3879-3881.
26. Li X., Yan Q., Xie S., et al. Gut microbiota contributes to the growth of fast-growing transgenic common carp (Cyprinus carpio L.). PLoS One 2013, 8:e64577.
27. Ley R.E., Bäckhed F., Turnbaugh P., et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005, 102:11070-11075.
28. Fang S., Evans R.E. Wealth management in the gut. Nature 2013, 500:538-539.
29. Atarashi K., Tanoue T., Oshima K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-239.
30. de Goffau M.C., Luopajärvi K., Knip M., et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013, 62:1238-1244.
31. Qin J., Li Y., Cai Z., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
32. Schwabe R.F., Wang T.C. Bacteria deliver a genotoxic hit. Science 2012, 338:52-53.
33. Arthur J.C., Perez-Chanona E., Mühlbauer M., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338:120-123.
34. Ezenwa V.O., Gerardo N.M., Inouye D.W., et al. Animal behavior and the microbiome. Science 2012, 338:198-199.
35. Das U.N. A Perinatal Strategy for Preventing Adult Diseases: The Role of Long-chain Polyunsaturated Fatty Acids 2002, Kluwer Academic Publishers, Boston.
36. Das U.N. Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids and their Metabolites 2010, Wiley-Blackwell Publishers, Ames, IA.
37. Das U.N. Molecular Basis of Health and Disease 2011, Springer, New York.
38. Zou Z., Bellenger S., Massey K.A., et al. Inhibition of the HER2 pathway n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice. J Lipid Res 2013, 54:3453-3463.
39. Mackay V.A., Huda S.S., Stewart F.M., et al. Preeclampsia is associated with compromised maternal synthesis of long-chain polyunsaturated fatty acids, leading to offspring deficiency. Hypertension 2012, 60:1078-1085.
40. Comte C., Bellenger S., Bellenger J., et al. Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver. Biochimie 2004, 86:799-806.
41. Zheng J.S., Hu X.J., Zhao Y.M., et al. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 2013, 346:f3706. 10.1136/bmj.f3706.
42. Das U.N. Essential fatty acids-a review. Curr Pharm Biotechnol 2006, 7:467-482.
43. Ruxton C.H., Calder P.C., Reed S.C., et al. The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutr Res Rev 2005, 18:113-129.
44. Sarbolouki S., Javanbakht M.H., Derakhshanian H., et al. Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial. Singapore Med J 2013, 54:387-390.
45. Andersen A.D., Mølbak L., Michaelsen K.F., et al. Molecular fingerprints of the human fecal microbiota from 9 to 18 months old and the effect of fish oil supplementation. J Pediatr Gastroenterol Nutr 2011, 53:303-309.
46. Zwielehner J., Liszt K., Handschur M., et al. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 2009, 44:440-446.
47. Correia M., Michel V., Matos A.A., et al. Docosahexaenoic acid inhibits Helicobacter pylori growth invitro and mice gastric mucosa colonization. PLoS One 2012, 7:e35072.
48. Obonyo M., Zhang L., Thamphiwatana S., et al. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm 2012, 9:2677-2685.
49. Sun C.Q., O'Connor C.J., Roberton A.M. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 2003, 36:9-17.
50. Das U.N. Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs. Prostaglandins Leukot Essent Fatty Acids 1998, 58:377-380.
51. Khulusi S., Ahmed H.A., Patel P., et al. The effects of unsaturated fatty acids on Helicobacter pylori invitro. J Med Microbiol 1995, 42:276-282.
52. Kelly O.J., Gilman J.C., Kim Y., et al. Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. Nutr Res 2013, 33:521-533.
53. Das U.N. Obesity: genes, brain, gut and environment. Nutrition 2010, 26:459-473.
54. Itariu B.K., Zeyda M., Leitner L., et al. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial. PLoS One 2013, 8:e54634.
55. Itariu B.K., Zeyda M., Hochbrugger E.E., et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr 2012, 96:1137-1149.
56. Spencer M., Finlin B.S., Unal R., et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 2013, 62:1709-1717.